Skip to main content
. 2023 May 10;5(3):100368. doi: 10.1016/j.ocarto.2023.100368

Table 2.

Results of the cost-effectiveness of WWE in patients with knee OA.

Inactive/insufficiently active cohort
Strategy QALEa Costs ICERb ($/QALY)
Usual Care 1.507 $16,012
Walk With Ease
1.513
$16,288
$47,900
All activity groups cohort
Strategy QALE Costs ICER ($/QALY)
Usual Care 1.532 $15,218
Walk With Ease 1.536 $15,526 $83,400
a

Quality-adjusted life expectancy.

b

Incremental cost-effectiveness ratio.